Literature DB >> 6965821

Adult-onset familial adrenal 21-hydroxylase deficiency.

J Blankstein, C Faiman, F I Reyes, M L Schroeder, J S Winter.   

Abstract

Two sisters (28 and 30 years) were investigated for primary infertility and milk hirsutism. Both had normal puberty, were having regular menses and had normal female sexual characteristics. Studies revealed elevated urinary 17-ketosteroid levels (15.8, 18.8 mg/24 hours) and increased serum levels of 17-OH-progesterone (2,756, 1,121 ng/dl), 21-desoxycortisol (1,882, 1,090 ng/dl), progesterone (300, 346 ng/dl), dehydroepiandrosterone (DHA) (1,600, 1,700 ng/dl), and androstenedione (402, 366 ng/dl) and testosterone (100, 104 ng/dl), together with a slight increase in serum 11-desoxycortisol (1,180, 1,560 ng/dl). Blood pressure, serum sodium/potassium plasma renin and serum aldosterone, corticosterone, 11-desoxycorticosterone and cortisol levels were normal. The administration of ACTH caused a further increase in 21-hydroxylase precursors; the administration of dexamethasone normalized hormone levels and produced ovulatory cycles. Similar studies in two siblings were normal. The affected sisters were HLA identical and did not share any HLA antigens with their healthy siblings. The data suggest that these patients have a mild form of 21-hydroxylase deficiency which was insufficient to cause prenatal virilization. The gene for this disorder may be allelic with that for typical congenital adrenal hyperplasia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6965821     DOI: 10.1016/0002-9343(80)90117-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

1.  High frequency of nonclassical steroid 21-hydroxylase deficiency.

Authors:  P W Speiser; B Dupont; P Rubinstein; A Piazza; A Kastelan; M I New
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

2.  Neonatal screening programme for congenital adrenal hyperplasia in a homogeneous Caucasian population.

Authors:  E Cacciari; A Balsamo; A Cassio; S Piazzi; F Bernardi; S Salardi; A Cicognani; P Pirazzoli; F Zappulla; M Capelli
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

3.  Neonatal screening for congenital adrenal hyperplasia.

Authors:  E Cacciari; A Balsamo; A Cassio; S Piazzi; F Bernardi; S Salardi; A Cicognani; P Pirazzoli; F Zappulla; M Capelli
Journal:  Arch Dis Child       Date:  1983-10       Impact factor: 3.791

4.  HLA and hormonal studies in 5 patients with late-onset 21-hydroxylase deficiency syndrome (21OHDS).

Authors:  C Scaroni; E Orlandini; C Venturi Pasini; M Gangemi; F Mantero
Journal:  J Endocrinol Invest       Date:  1986-02       Impact factor: 4.256

5.  The immunological detection of a 21-OH deficiency mutation HLA supratype.

Authors:  M S Pollack; B Keenan; F T Christiansen; T J Cobain; R L Dawkins; G Clayton
Journal:  Am J Hum Genet       Date:  1986-05       Impact factor: 11.025

6.  HLA linkage and B14, DR1, BfS haplotype association with the genes for late onset and cryptic 21-hydroxylase deficiency.

Authors:  M S Pollack; L S Levine; G J O'Neill; S Pang; F Lorenzen; B Kohn; G F Rondanini; G Chiumello; M I New; B Dupont
Journal:  Am J Hum Genet       Date:  1981-07       Impact factor: 11.025

7.  The biochemical basis for genotyping 21-hydroxylase deficiency.

Authors:  M I New; B Dupont; M S Pollack; L S Levine
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.